ghk cu peptide safety human studies GHK-Cu (Copper Peptide) 50mg & 100mg GHK-CU – Research Peptide |
Description
It was approved in 2012 by the FDA for the treatment of medullary thyroid cancer and renal cell cancer
Y.et al (2021d)
Possible supportive effects of co-dergocrine mesylate on antioxidant enzyme systems in aged rat brain
Collettini A, Zoccali F, Barbato C, Minni A
Edema, attributable to the surgical intervention, was detected after the initial week but entirely resolved over time
